Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (FRA:FDY)

FRA:FDY Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,119	1,056	1,196	1,289	1,209	1,397
Short-Term Investments	-	-	-	30	-	-
Cash & Short-Term Investments	1,119	1,056	1,196	1,319	1,209	1,397
Cash Growth	7.71%	-11.67%	-9.35%	9.13%	-13.46%	142.18%
Accounts Receivable	365.09	469.96	620.49	679.12	672.49	583.1
Other Receivables	2.6	0.07	0.16	5.14	1.18	0.91
Receivables	367.68	470.03	620.64	684.26	673.66	584
Inventory	31.04	47.27	43.65	40.53	35.63	36.01
Other Current Assets	18.24	33.2	9.24	25.1	9.77	9.67
Total Current Assets	1,536	1,607	1,869	2,069	1,928	2,027
Property, Plant & Equipment	476.81	503.53	475.33	351.51	301.92	248.77
Long-Term Investments	249.31	257.49	287.53	306.37	327.86	66.71
Other Intangible Assets	64.04	68.65	86.35	62.32	88.46	56.18
Long-Term Deferred Tax Assets	133.28	133.28	100.87	85.9	79.22	62.97
Long-Term Deferred Charges	-	-	-	43.09	36.12	32.53
Other Long-Term Assets	6.79	16.77	57.18	57.62	19.64	6.97
Total Assets	2,466	2,587	2,877	2,976	2,781	2,501
Accounts Payable	5.67	10.67	8.05	7.43	8.17	5.27
Accrued Expenses	2.11	28.69	36.86	34.67	53.78	48.73
Short-Term Debt	-	-	-	101	-	-
Current Portion of Leases	5.31	6.1	6.33	8.22	8.68	6.09
Current Income Taxes Payable	9.27	-	1.61	1.63	10.4	4.6
Current Unearned Revenue	5.96	8.34	0.26	0.31	348.87	297.01
Other Current Liabilities	148.58	197.16	451.9	520.09	98.3	66.22
Total Current Liabilities	176.89	250.95	505.02	673.34	528.2	427.93
Long-Term Leases	10.65	14.43	10.95	15.6	22.59	13.6
Long-Term Unearned Revenue	19.51	15.85	2.15	34.04	40.8	50.69
Total Liabilities	207.05	281.23	518.12	722.99	591.58	492.21
Common Stock	103.66	103.66	103.66	102.9	104.3	104.3
Additional Paid-In Capital	1,291	1,290	1,289	1,225	1,265	1,200
Retained Earnings	869.87	916.9	970.46	934.39	868.43	707.28
Treasury Stock	-	-	-	-	-40.82	-
Comprehensive Income & Other	-5.81	-5.55	-5.86	-5.2	-4.05	-0.77
Total Common Equity	2,258	2,305	2,358	2,257	2,193	2,011
Minority Interest	0.51	0.71	1.01	-4.08	-3.36	-2.44
Shareholders' Equity	2,259	2,305	2,359	2,253	2,190	2,008
Total Liabilities & Equity	2,466	2,587	2,877	2,976	2,781	2,501
Total Debt	15.95	20.53	17.28	124.81	31.26	19.69
Net Cash (Debt)	1,103	1,036	1,179	1,194	1,178	1,377
Net Cash Growth	7.34%	-12.12%	-1.33%	1.43%	-14.49%	226.58%
Net Cash Per Share	1.34	1.00	1.14	1.16	1.13	1.39
Filing Date Shares Outstanding	1,037	1,037	1,037	1,029	1,032	1,043
Total Common Shares Outstanding	1,037	1,037	1,037	1,029	1,032	1,043
Working Capital	1,359	1,356	1,364	1,396	1,400	1,599
Book Value Per Share	2.18	2.22	2.27	2.19	2.12	1.93
Tangible Book Value	2,194	2,236	2,271	2,195	2,104	1,955
Tangible Book Value Per Share	2.12	2.16	2.19	2.13	2.04	1.87
Buildings	-	368.53	199.22	198.52	198.52	197.33
Machinery	-	504.91	388.63	341.74	322.86	292.69
Construction In Progress	-	7.2	229.96	122.37	48.9	1.83

Source: S&P Global Market Intelligence. Standard template. Financial Sources.